| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.16 | 0.6 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |